Lymphoma in Dogs: Signs, Symptoms, and Chemotherapy Guide
Lymphoma accounts for 7-24% of all canine tumors. Learn the early signs of lymphoma in dogs, what chemotherapy involves, and what long-term outcomes look like.
Most dogs with lymphoma are found by their owners during a bath or a routine petting session. A lump behind the jaw, a firm swelling under an arm, a node that wasn't there last month. Lymphoma is one of the most common cancers in dogs, accounting for 7 to 24% of all canine tumor diagnoses (Vail & Young, Withrow and MacEwen's Small Animal Clinical Oncology), and in many cases a pet owner is the first one to find it.
Understanding what lymphoma is, what it looks like, how it's treated, and what the numbers actually mean makes every conversation with a vet more productive. This article covers all of it. dog cancer overview
What to Know Canine lymphoma accounts for 7 to 24% of all dog cancer diagnoses and is among the most common malignancies in dogs. Without treatment, median survival is 4 to 6 weeks. With the gold-standard CHOP chemotherapy protocol, B-cell lymphoma carries a median survival of 12 to 14 months and a complete remission rate of 65 to 90% (Vail & Young; Chun et al., 2007).
The Lymph Nodes Are Always the First Clue
Lymphoma is cancer of the lymphocytes, the white blood cells that circulate through the lymphatic system and reside in lymph nodes throughout the body. When those cells become malignant, they multiply uncontrollably and cause the lymph nodes to enlarge, sometimes dramatically.
The most common form in dogs is multicentric lymphoma, accounting for roughly 80 to 85% of all canine cases (Vail & Young). In this form, multiple lymph node groups enlarge simultaneously or in rapid succession. The nodes are typically firm, rubbery, non-painful, and discrete. They don't feel like an infected node (which tends to be warm, tender, and associated with a visible wound or infection nearby). They just get bigger.
The six most accessible lymph node groups in dogs are the submandibular (under the jaw), prescapular (in front of the shoulder blade), axillary (armpit), inguinal (groin), popliteal (behind the knee), and mesenteric (inside the abdomen, only found on ultrasound). In multicentric lymphoma, all or most of these can be involved.
Citation Capsule: Multicentric lymphoma accounts for approximately 80 to 85% of all canine lymphoma diagnoses and typically presents as bilateral, non-painful lymphadenopathy across multiple node groups simultaneously (Vail & Young, Withrow and MacEwen's Small Animal Clinical Oncology, 6th ed.). Affected nodes are characteristically firm, rubbery, and discrete, distinguishing them from reactive or infected nodes, which tend to be warm and painful on palpation.
What Are the Early Signs of Lymphoma in Dogs?
The signs depend heavily on which form of lymphoma the dog has, and form determines where in the body the cancer is actively growing.
Multicentric lymphoma (80-85% of cases): Visibly or palpably enlarged lymph nodes are the defining feature. Many dogs feel entirely normal at first, eating well and maintaining energy. As disease advances, lethargy, decreased appetite, weight loss, and increased thirst or urination develop. The substage designation captures this: substage a means no systemic illness signs, substage b means systemic signs are present. Substage b carries a measurably worse prognosis.
Alimentary (gastrointestinal) lymphoma: Dogs with GI lymphoma present with vomiting, diarrhea, weight loss, and protein-losing enteropathy. Lymph node enlargement may not be visible externally. This form is less common in dogs than in cats.
Mediastinal lymphoma: Affects lymph nodes and sometimes the thymus in the chest. Respiratory signs dominate: coughing, labored breathing, and exercise intolerance from pleural effusion. Facial and forelimb swelling can occur if the cranial vena cava is compressed.
Epitheliotropic (cutaneous) lymphoma: Presents as scaling, itching, depigmentation, nodular skin lesions, or mucocutaneous ulceration. It often mimics inflammatory skin disease and can go undiagnosed through multiple rounds of allergy treatment.
One sign worth flagging independently: excessive thirst and urination in a dog with enlarged lymph nodes is a strong indicator of hypercalcemia, which occurs in approximately 30 to 40% of dogs with T-cell lymphoma (Weir et al., 2011). Hypercalcemia is a metabolic emergency and also a prognostic red flag. dog lymph node swelling
Citation Capsule: Hypercalcemia of malignancy occurs in approximately 30 to 40% of dogs with T-cell lymphoma and is associated with significantly shorter remission duration and survival times compared to normocalcemic dogs (Weir et al., 2011). Dogs presenting with polyuria, polydipsia, and generalized lymphadenopathy should be evaluated for hypercalcemia before other workup proceeds, as it constitutes a concurrent metabolic emergency requiring immediate management.
How Do Vets Diagnose Lymphoma in Dogs?
Fine needle aspiration (FNA) of an enlarged lymph node is the first step in almost every case. In multicentric lymphoma, the cytological appearance of the aspirate is quite characteristic: sheets of large, immature lymphocytes with prominent nucleoli and scant cytoplasm. Experienced cytologists diagnose multicentric lymphoma from FNA with approximately 80 to 90% accuracy (Ghisleni et al., 2006). fine needle aspiration dogs
Histopathology from a node biopsy is required when FNA is inconclusive, when a definitive grade is needed for treatment planning, or when GI or cutaneous lymphoma is suspected. Histopathology provides grading (low-grade vs. high-grade) and architecture information not available from cytology.
Immunophenotyping determines whether the lymphoma is B-cell or T-cell. This is done by flow cytometry on a fresh sample or by immunohistochemistry on a biopsy. B-cell vs. T-cell designation is the single most important prognostic factor after diagnosis, and the treatment plan can differ based on the result.
When immunophenotyping is inconclusive, PARR (PCR for antigen receptor rearrangements) is a molecular test that can determine clonality and lineage. Staging tests complete the picture: complete blood count, serum chemistry (calcium is critical), chest X-rays, and abdominal ultrasound determine what stage the disease has reached and whether the bone marrow is involved.
Citation Capsule: Fine needle aspiration of enlarged lymph nodes provides a cytological diagnosis in approximately 80 to 90% of multicentric lymphoma cases, but immunophenotyping via flow cytometry or immunohistochemistry is required to distinguish B-cell from T-cell lymphoma, which has a direct and significant impact on prognosis and treatment response (Bhang et al., 2018). Skipping immunophenotyping means treating without knowing which protocol offers the best expected outcome.
Does Cell Type Determine How Long a Dog Survives?
Yes, and the difference is substantial. Immunophenotype is consistently identified as the strongest independent predictor of remission duration and survival in canine lymphoma.
B-cell lymphoma makes up approximately 65 to 70% of cases and responds better to chemotherapy at every measured timepoint. Dogs with B-cell lymphoma treated with CHOP achieve complete remission in 65 to 90% of cases, with a median survival of 12 to 14 months (Vail et al., 2021). Approximately 40 to 50% survive past 1 year, and 20 to 25% reach 2 years.
T-cell lymphoma accounts for 30 to 35% of cases. Response rates to CHOP are lower, remission durations shorter, and median survival approximately 6 months (Vail et al., 2021). Hypercalcemia, which clusters heavily in T-cell cases, adds further negative prognostic weight.
Beyond immunophenotype, substage matters. Dogs in substage a (no illness signs) consistently outlive substage b dogs across all studies. Stage at diagnosis, the dog's performance status, and serum albumin level each add prognostic information layered on top of cell type.
Citation Capsule: B-cell lymphoma achieves complete remission in 65 to 90% of CHOP-treated dogs with a median survival of 12 to 14 months; T-cell lymphoma achieves lower response rates and carries a median survival of approximately 6 months under the same protocol (Vail et al., 2021). This two-fold survival difference makes immunophenotyping not an optional refinement but a necessary step before any treatment decision is finalized.
What Does Chemotherapy for Dogs with Lymphoma Actually Look Like?
CHOP is the gold-standard protocol for canine lymphoma and the one against which all other approaches are measured. The name is an acronym for its four components.
CHOP Protocol Components (UW-25)
| Drug | Abbreviation | Mechanism | Typical Schedule |
|---|---|---|---|
| Cyclophosphamide | C | DNA cross-linking (alkylating agent) | Every 3 weeks |
| Doxorubicin (Hydroxydaunorubicin) | H | DNA intercalation (anthracycline) | Every 3 weeks |
| Vincristine (Oncovin) | O | Spindle inhibition (vinca alkaloid) | Approximately weekly for first 5 weeks |
| Prednisone | P | Lymphocyte apoptosis (corticosteroid) | Daily for first 4 weeks |
The standard University of Wisconsin 25-week protocol (UW-25) runs for 25 weeks with a combination of weekly and biweekly treatments in the first half, then spacing out. Dogs typically come in for a treatment or check-in visit every one to three weeks.
Most dogs tolerate CHOP well. Studies consistently report that approximately 70 to 80% of dogs experience minimal to no significant side effects during treatment (Vail et al., 2021). Mild GI upset (vomiting, soft stools, decreased appetite for 24 to 48 hours post-treatment) is the most common issue. Hair coat changes occur in some breeds, particularly poodles and Old English Sheepdogs, due to continuous hair growth cycles. Serious complications (neutropenic fever, sepsis) occur in approximately 10 to 15% of cycles and are typically managed with hospitalization and antibiotics.
What oncologists observe consistently: The owners who report the most positive treatment experiences are those briefed in detail before the first dose, not after. Knowing that a dog might be quiet for two days after doxorubicin, or that a temperature check is needed if the dog seems unwell during week 2, prevents the phone calls that would otherwise lead to an emergency visit. Pre-treatment counseling time is clinical time. CHOP protocol dogs
One of the most important cautions in canine lymphoma treatment is rarely stated clearly to pet owners before they see a specialist: giving prednisone before starting CHOP chemotherapy significantly compromises the treatment's effectiveness. Prednisone alone produces temporary remission by killing some lymphoma cells, but it simultaneously selects for cells that carry multiple-drug resistance mechanisms. Dogs pre-treated with prednisone for weeks before chemotherapy achieve complete remission at substantially lower rates than those who start CHOP first (Brodsky et al., 2009). If a general vet recommends starting prednisone while waiting for an oncology appointment, that delay is not neutral. It can meaningfully reduce what CHOP will accomplish.
Citation Capsule: Pre-treatment with prednisone before initiating CHOP chemotherapy is associated with significantly lower complete remission rates in dogs with lymphoma, because corticosteroid exposure selects for multidrug-resistant lymphoma cell populations (Brodsky et al., 2009). Owners waiting for an oncology referral should discuss this risk explicitly with their general vet, as the decision to use prednisone first carries measurable treatment consequences that are difficult to reverse. chemotherapy side effects dogs
Prognosis by the Numbers: Survival Rates Across Treatment Options
The gap between treating and not treating canine lymphoma is among the largest in veterinary oncology. Understanding the numbers makes the treatment conversation more concrete.
Dogs in complete remission after CHOP are not cured in most cases. They're in remission, which means no detectable disease. The distinction matters because most dogs relapse, typically within 6 to 12 months. A second remission can be achieved, though at lower rates and shorter durations than the first. Protocols like MOPP (mechlorethamine, vincristine, procarbazine, prednisone) are used for relapsed dogs.
Long-term cure, defined as disease-free survival at 2 years or more, occurs in approximately 20 to 25% of CHOP-treated B-cell lymphoma cases. For T-cell lymphoma, this figure is significantly lower. The realistic framing for most owners: the goal of treatment is to achieve complete remission and extend a good-quality life by 12 to 14 months, not to produce a permanent cure.
Citation Capsule: Long-term survival (2 years or more) is achieved in approximately 20 to 25% of CHOP-treated dogs with B-cell lymphoma; for T-cell lymphoma, that proportion is substantially lower (Vail et al., 2021). Dogs without treatment have a median survival of 4 to 6 weeks, making the gap between treatment and no treatment among the largest of any cancer in veterinary oncology. Remission, rather than cure, remains the realistic framing for most cases.
What About Lymphoma in Cats?
In cats, lymphoma is also the most commonly diagnosed cancer, but the disease behaves very differently from its canine counterpart. The form and grade define everything.
The most common form in cats is alimentary (gastrointestinal) lymphoma, not multicentric. Cats with GI lymphoma present with weight loss, vomiting, diarrhea, and decreased appetite. External lymph node enlargement may be minimal or absent. An abdominal mass on ultrasound is often the first diagnostic finding.
The most striking aspect of feline lymphoma, and one of the most dramatic prognosis splits in all of veterinary oncology, is the gap between small cell (low-grade) and large cell (high-grade) GI lymphoma in cats. Small cell lymphoma treated with oral chlorambucil and prednisone carries a median survival of approximately 700 to 900 days (Kiselow et al., 2008). Large cell lymphoma treated with CHOP carries a median survival of approximately 60 to 90 days. The word "lymphoma" covers both of these diseases, but in cats, grade is nearly everything. Many cats diagnosed with small cell GI lymphoma live comfortably for 2 to 3 years with nothing more than twice-weekly oral medication. lymphoma in cats
Citation Capsule: Small cell (low-grade) gastrointestinal lymphoma in cats treated with oral chlorambucil and prednisone achieves a median survival of approximately 700 to 900 days in published case series (Kiselow et al., 2008), compared to a median survival of 60 to 90 days for cats with large cell (high-grade) GI lymphoma. This survival differential of roughly 10-fold makes grade determination in feline lymphoma as prognostically critical as immunophenotyping in canine cases.
Frequently Asked Questions
How do I know if my dog's lymph nodes are swollen?
The most accessible lymph nodes in dogs are the submandibular nodes (under the jaw on each side), the prescapular nodes (at the front of each shoulder), and the popliteal nodes (behind each knee). Swollen nodes feel like firm, rubbery, movable lumps under the skin, roughly the size of a grape or larger in affected dogs. Normal nodes are usually so small they're difficult to feel. If a node is visible as a bump or easily palpable in a previously smooth area, it warrants evaluation.
Can lymphoma in dogs be cured?
For B-cell lymphoma treated with CHOP, approximately 20 to 25% of dogs reach 2-year survival, which most oncologists consider functional cure. Most dogs experience a remission of 12 to 14 months before relapse. T-cell lymphoma has lower cure rates. The realistic framing for most newly diagnosed dogs is that CHOP extends high-quality life substantially compared to no treatment, but does not permanently eliminate the disease in the majority of cases.
How long do dogs live with lymphoma without treatment?
The median survival without any treatment is 4 to 6 weeks from the time of diagnosis (Vail & Young, Withrow and MacEwen's). Prednisone alone extends this to approximately 1 to 2 months but also compromises the effectiveness of subsequent chemotherapy by promoting multidrug resistance.
What is the CHOP protocol for dogs with lymphoma?
CHOP stands for Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone. The University of Wisconsin 25-week protocol (UW-25) is the most commonly used version in North America. Treatment runs 25 weeks with weekly or biweekly clinic visits. Complete remission rates range from 65 to 90% (Vail et al., 2021), and most dogs tolerate the protocol well with minimal quality-of-life impact. finding a veterinary oncologist
Can prednisone harm my dog's chances if given before chemotherapy?
Yes, meaningfully. Studies have shown that prior corticosteroid exposure reduces the complete remission rate in dogs subsequently treated with CHOP (Brodsky et al., 2009). This happens because prednisone selects for multidrug-resistant cell populations. If your general vet recommends starting prednisone while waiting for an oncology appointment, discuss the timing explicitly. A short course may be unavoidable for symptom management, but the decision should be made with this risk clearly understood.
Making the Decision With All the Information
The options for canine lymphoma span a wide range, from curative-intent CHOP chemotherapy to palliative prednisone to no treatment at all. Each is appropriate depending on the dog's health, the owner's goals, and the disease characteristics. What narrows the range to the right option is having accurate diagnostic information: immunophenotype, stage, substage, and a direct conversation with an oncologist about what the numbers mean for that specific dog.
The test that matters most in the first week after diagnosis isn't additional imaging or bloodwork. It's immunophenotyping of the lymphoma. That single result shapes everything else.
canine lymphoma staging
